BDSX
Biodesix IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$151.42M
P/E Ratio
—
EPS
$-4.67
Beta
0.57
52W High
$20.21
52W Low
$3.44
50-Day MA
$13.84
200-Day MA
$9.04
Dividend Yield
—
Profit Margin
-39.90%
Forward P/E
—
PEG Ratio
—
About Biodesix Inc
Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company is headquartered in Boulder, Colorado.
Fundamentals
| Revenue (TTM) | $88.50M |
| Gross Profit (TTM) | $71.78M |
| EBITDA | $-22.10M |
| Operating Margin | -6.84% |
| Return on Equity | -383.10% |
| Return on Assets | -18.80% |
| Revenue/Share (TTM) | $11.72 |
| Book Value | $-0.30 |
| Price-to-Book | 44.57 |
| Price-to-Sales (TTM) | 1.71 |
| EV/Revenue | 2.293 |
| EV/EBITDA | -2.72 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 40.80% |
| Shares Outstanding | $9.86M |
| Float | $5.35M |
| % Insiders | 44.18% |
| % Institutions | 22.64% |
Analyst Ratings
Consensus ($30.00 target)
5
BuyData last updated: 4/7/2026